MC Frühwald, JA Biegel, F Bourdeaut… - Neuro …, 2016 - academic.oup.com
Atypical teratoid/rhabdoid tumor (AT/RT) is the most common malignant CNS tumor of children below 6 months of age. The majority of AT/RTs demonstrate genomic alterations in …
J Theruvath, E Sotillo, CW Mount, CM Graef… - Nature medicine, 2020 - nature.com
Atypical teratoid/rhabdoid tumors (ATRTs) typically arise in the central nervous system (CNS) of children under 3 years of age. Despite intensive multimodal therapy (surgery …
A Gajjar, DC Bowers, MA Karajannis… - Journal of Clinical …, 2015 - ascopubs.org
Pediatric neuro-oncology has undergone an exciting and dramatic transformation during the past 5 years. This article summarizes data from collaborative group and institutional trials …
MC Frühwald, M Hasselblatt, K Nemes, S Bens… - Neuro …, 2020 - academic.oup.com
Background Controversy exists as to what may be defined as standard of care (including markers for stratification) for patients with atypical teratoid/rhabdoid tumors (ATRTs). The …
J Torchia, D Picard, L Lafay-Cousin… - The lancet …, 2015 - thelancet.com
Background Rhabdoid brain tumours, also called atypical teratoid rhabdoid tumours, are lethal childhood cancers with characteristic genetic alterations of SMARCB1/hSNF5. Lack of …
KF Ginn, A Gajjar - Frontiers in oncology, 2012 - frontiersin.org
Atypical teratoid rhabdoid tumors (ATRTs) are rare central nervous system tumors that comprise approximately 1–2% of all pediatric brain tumors; however, in patients less than 3 …
D Pratt, F Sahm, K Aldape - Neuro-oncology, 2021 - academic.oup.com
Recent years have witnessed a shift to more objective and biologically-driven methods for central nervous system (CNS) tumor classification. The 2016 world health organization …
BACKGROUND: Atypical teratoid rhabdoid tumor (ATRT) is a rare central nervous system malignancy with a poor prognosis that affects mostly young children. Although radiotherapy …
SA Upadhyaya, GW Robinson, A Onar-Thomas… - Clinical cancer …, 2021 - AACR
Purpose: Report relevance of molecular groups to clinicopathologic features, germline SMARCB1/SMARCA4 alterations (GLA), and survival of children with atypical teratoid …